Cost-Effectiveness of the Third-Agent Class in Treatment-Naive Human Immunodeficiency Virus-Infected Patients in Portugal

Open Access

Peer-reviewed

Research Article

Filipa Aragão ,

* E-mail: filipaaragao@gmail.com

Affiliations Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Lisboa, Lisboa, Portugal, Associação SER+, Rua André Homem, Cascais, Cascais, Portugal
⨯
José Vera,

Affiliation HPP - Hospital de Cascais, Alcabideche, Cascais, Portugal
⨯
Inês Vaz Pinto

Affiliation HPP - Hospital de Cascais, Alcabideche, Cascais, Portugal
⨯

Reader Comments (0)

AIDS
Is the Subject Area "AIDS" applicable to this article?

Thanks for your feedback.
Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Cost-effectiveness analysis
Is the Subject Area "Cost-effectiveness analysis" applicable to this article?

Thanks for your feedback.
HIV infections
Is the Subject Area "HIV infections" applicable to this article?

Thanks for your feedback.
Reverse transcriptase inhibitors
Is the Subject Area "Reverse transcriptase inhibitors" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Protease inhibitor therapy
Is the Subject Area "Protease inhibitor therapy" applicable to this article?

Thanks for your feedback.
Viral load
Is the Subject Area "Viral load" applicable to this article?

Thanks for your feedback.